当前位置：
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE Trial.
European Urology ( IF 23.4 ) Pub Date : 2021-07-14 , DOI: 10.1016/j.eururo.2021.06.023 Gerhardt Attard 1 , Louise C Brown 2 , Noel W Clarke 3 , Mahesh K B Parmar 2 , Nicholas D James 4
中文翻译：
除雄激素剥夺治疗外，高危局部或局部晚期前列腺癌患者是否应接受醋酸阿比特龙治疗？对 STAMPEDE 试验的计划分析的更新。
更新日期：2021-07-14
European Urology ( IF 23.4 ) Pub Date : 2021-07-14 , DOI: 10.1016/j.eururo.2021.06.023 Gerhardt Attard 1 , Louise C Brown 2 , Noel W Clarke 3 , Mahesh K B Parmar 2 , Nicholas D James 4
Affiliation
中文翻译：
除雄激素剥夺治疗外，高危局部或局部晚期前列腺癌患者是否应接受醋酸阿比特龙治疗？对 STAMPEDE 试验的计划分析的更新。
京公网安备 11010802027423号